Larimar Therapeutics, Inc. (LRMR) › Total AssetsLarimar Therapeutics, Inc. (LRMR) — Total AssetsAnnual figures by fiscal year, from SEC filings.2013: $38.14M2014: $117.52M2015: $189.11M2016: $131.62M2017: $105.51M2018: $121.76M2019: $5.20M2020: $104.69M2021: $78.67M2022: $126.41M2023: $95.94M2024: $200.22M2025: $145.84M$145.84M2013Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$145.84M-27.2%2024$200.22M+108.7%2023$95.94M-24.1%2022$126.41M+60.7%2021$78.67M-24.9%2020$104.69M+1912.8%2019$5.20M-95.7%2018$121.76M+15.4%2017$105.51M-19.8%2016$131.62M-30.4%2015$189.11M+60.9%2014$117.52M+208.1%2013$38.14M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share